Development Status & Partnering Opportunities

Ipsat’s strategy is to develop its products to the proof of concept stage. Thereafter, the Company wishes to establish partnerships with interested parties.

Product*	Antibiotics	Route	Status
P1A	Penicillins	Parenteral	Phase II
P2A	Penicillins, Cephalosporins, Carbapenems	Parenteral	Preclinical
P3A	New antibiotics	Parenteral	Research
P1B	Penicillins	Oral	Co-dev opportunity
P2B	Penicillins, Cephalosporins, Carbapenems	Oral	Co-dev opportunity
P1C	Fixed combination products	Oral	Co-dev opportunity
P2C	Fixed combination products	Oral	Co-dev opportunity